A good night’s sleep often sets the stage for a positive day. But for the nearly quarter of American adults struggling with ...

NSDUH only queried opioid misusers about opioid use disorder symptoms. After they changed the protocol and asked all ...

Opioid dependency represents one of the most challenging public health crises of our time. It's a condition that doesn't discriminate, affecting people from all walks of life. The consequences are far ...

More New Yorkers received scripts for buprenorphine, a med used to treat opioid addiction, amid fight against record-high ...

"Addressing people in the throws of addiction is frustrating ... not only in treating withdrawal symptoms, but in reducing opioid use and then reducing the risk of death," he added of buprenorphine.

Now a third option is available after the U.S. Food and Drug Administration last week approved Vertex Pharmaceuticals’ ...

Washington — Federal officials on Thursday approved a new type of pain drug designed to eliminate the risks of addiction and overdose associated with opioid medications like Vicodin and OxyContin.

The prescription pills, sold under the brand name Journavx and made by Vertex Pharmaceuticals, are taken twice a day and ...

It is the first new class of non-opioid pain medicine approved in over 20 years, providing effective pain relief without the risk of addiction that can come with opioids. Acute pain is short-term ...

Suzetrigine prevents pain signals from reaching the brain and doesn't give an opioid-like high, making it non-addictive—but ...

Reducing cravings is important because it lowers the likelihood of relapse and helps people stay committed to their recovery ...